Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that Matisse’s lead compound M6229, has received the International ...

Perrigo (PRGO) is back in the spotlight after a wave of class action lawsuits hit the company, following weak quarterly results, a lowered 2025 outlook, and a strategic review of its infant formula ...

Are you unknowingly overdosing on salt every day? Cardiologist reveals 7 high-sodium Indian foods you must avoid to keep your blood pressure in check. Most of us add a pinch of salt here and there ...

Infant-formula maker ByHeart has recalled all of its products in the U.S. after they were linked to a multistate botulism outbreak. A total of 15 infants with suspected or confirmed cases of botulism ...

A new class action lawsuit filed in California against Toyota is demanding an extraordinary $5.7 billion in damages, accusing the company of running a criminal operation to hide serious safety flaws ...

Formula 1 is moving from its home with ESPN to Apple TV, and that means YouTube TV will no longer be the place to watch F1 racing. Apple TV has officially won the rights to air Formula 1 exclusively ...

The Georgia High School Association voted 66-1 this month to choose and seed playoff teams using a points formula beginning in 2026-27. The plan will apply to all sports that use 32-team playoff ...

Japanese researchers have developed a green rust–based catalyst for sodium borohydride, while South Korean scientists have created a framework to assess liquid hydrogen storage tanks for unmanned ...

Can you really carbonate fruit? Absolutely. We figured out a simple way to carbonate everything from cucumbers to watermelon. And all it took was some dry ice, patience, and a LOT of fruit, but ...

Diversified global manufacturer Asahi Kasei will supply its Aqualyzer™-C3 containerized 1 MW-class alkaline-water electrolyzer to the Central Finland Mobility Foundation (Cefmof). The system will play ...

Unicycive Therapeutics shares tumbled more than 20% in premarket trading Monday after the Food and Drug Administration turned away the company's proposed treatment for an electrolyte disorder in ...